Mass. Biotech Company Closes $132M Series A Fundraising
Massachusetts-based biotechnology company Compass Therapeutics said Thursday that it has closed on the final $49 million of its $132 million series A financing that will be used to push its latest...To view the full article, register now.
Already a subscriber? Click here to view full article